JAK3 and primary cutaneous T-cell non-Hodgkin lymphoma: Nuclear JAK3 is detected in cutaneous T cell lymphoma (CTCL) and primary malignant T cells in patients with Sézary syndrome, indicating its role in the pathogenesis of these conditions [87].